|
(L1) 6501.2438-Amantadine, 100 Mg, Tablet, Blister, Route Of Administration: Oral, Ordinance 344/98: C1, Units. Size: Unit, (L2) 6501.256-Amikacin, Sulfate, 50 Mg/Ml (100 Mg), Injectable Solution, Ampoule, 2 Ml, Route Of Administration: Intramuscular/Intravenous, (L3) 6501.304-Bupivacaine, Hydrochloride + Glucose, 5 Mg/Ml (0.5%) + 80 Mg/Ml (8%), 4 Ml, Route Of Administration: Other Parenteral Routes, (L4) 6501.84825-Ceftarolina Fosamila, 600 Mg, Powder For Injectable Solution, Ampoule Vial, Route Of Administration: Intravenous, (L5) 6501.4694-Cefuroxime Sodium, 750 Mg, 11/27/2025 - 10:00:04, (L6) 6502.1079-Clobazam, 10 Mg, Ordinance 344/98: B1, (L7) 6502.1092-Codeine, Phosphate, 3 Mg/Ml, Oral Solution, Bottle, 120 Ml, Dosing Cup/Syringe, Ordinance 344/98: A2, (L8) 6502.1098-Diazepam, 5 Mg/Ml, (L9) 6502.1105-Phenytoin, (L10) 6502.61341-Lacosamide, 10 Mg/Ml, 200 Ml, (L11) 6501.40572-Lidocaine + Prilocaine, Cream, Lidocaine: 25 Mg/G, Prilocaine: 25 Mg/G, Tube, Total Composition: 5G, (L12) 6501.909-Nitrofurantoin, Capsule, (L13) 6502.84669-Parecoxib, 40 Mg, Lyophilized Powder For Injection Solution, (L14) 6502.1189-Sevoflurane, 100%, Inhalant Liquid, 250 Ml, Route Of Administration: Inhalation, (L15) 6501.964-Sulfadiazine, 500 Mg, (L16) 6502.1021-Valproic Acid / Sodium Valproate, 250 Mg, Blister/Vial
|
